News

Al Harith now dreams of becoming a radiology specialist. "I want to help patients, to be a reason for alleviating their pain, ...
Sickle cell anemia is a hereditary blood disorder resulting from mutations in genes responsible for hemoglobin formation. These mutations cause a change in the shape of red blood cells from round to ...
A Northeast Ohio woman and a 22-year-old man from UAE are among the first patients to receive the innovative CRISPR treatment.
Beta thalassemia, a blood condition that causes low levels of functional red blood cells, may cause mild to severe anemia.
An overview of World Sickle Cell Anemia Day 2025 and the global and local challenges of managing sickle cell disease.
Trending News: Japanese scientists have achieved a breakthrough by developing a universal, virus-free artificial blood substitute. This innovation, based on hemoglob ...
Scientists have discovered that the internal shape of tiny drug-delivery particles—called lipid nanoparticles—has a big impact on how well our cells absorb them, paving the way to more ...
Haematopoietic stem cells are progenitor cells that have the ability to both generate all types of blood cells, including those of the myeloid and lymphoid lineages, and to replace themselves. In ...
Minister of State, Public Health & Family Welfare, Maharashtra, Meghana Bordikar, said on Thursday that couples may soon need ...
Deferiprone market was valued at US$ 39.89 million in 2024 and is projected to hit the market valuation of US$ 55.22 million by 2033 at a CAGR of 3.68% during the forecast period 2025–2033.